Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Targeted Temperature Management on Cerebral Autoregulation in Patients With Neurocritical Diseases

NCT04728438 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT04728438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04728438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Targeted Temperature Management on Cerebral Autoregulation in Patients With Neurocritical Diseases
Lead sponsor
Xiangya Hospital of Central South University
Phase
Observational
Overall status
Unknown status
Start date
January 22, 2021
Completion date
July 1, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hie - hypoxic - ischemic encephalopathy, ich - intracerebral hemorrhage, ischemic stroke, sepsis, subarachnoid hemorrhage, aneurysmal, tbi (traumatic brain injury)